Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

Albumin

"27 plasma exchange procedures using Albumin 5% (estimated 3000 mL per plasma exchange) as replacement solution:~* three weeks of intensive treatment with two plasma exchanges per week~* twenty-one weeks of maintenance treatment with one weekly plasma exchange"

Trial Locations (1)

08907

Hospital Universitari Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Instituto Grifols, S.A.

INDUSTRY

NCT02479802 - Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter